173 related articles for article (PubMed ID: 22044424)
1. Meeting the need for regenerative therapies I: target-based incidence and its relationship to U.S. spending, productivity, and innovation.
Parenteau N; Hardin-Young J; Shannon W; Cantini P; Russell A
Tissue Eng Part B Rev; 2012 Apr; 18(2):139-54. PubMed ID: 22044424
[TBL] [Abstract][Full Text] [Related]
2. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
[TBL] [Abstract][Full Text] [Related]
3. Value-engineered translation for regenerative medicine: meeting the needs of health systems.
Bubela T; McCabe C
Stem Cells Dev; 2013 Dec; 22 Suppl 1(Suppl 1):89-93. PubMed ID: 24304083
[TBL] [Abstract][Full Text] [Related]
4. California Institute for Regenerative Medicine: accelerating stem cell therapies in California and beyond.
Trounson A
Stem Cells Transl Med; 2012 Jan; 1(1):6-8. PubMed ID: 23197633
[No Abstract] [Full Text] [Related]
5. Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry.
Bock AJ; Johnson D
Adv Exp Med Biol; 2018; 1098():213-236. PubMed ID: 30238374
[TBL] [Abstract][Full Text] [Related]
6. Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.
Johnson S
Stem Cells Dev; 2013 Dec; 22 Suppl 1():85-8. PubMed ID: 24304082
[No Abstract] [Full Text] [Related]
7. The Alpha Stem Cell Clinic: a model for evaluating and delivering stem cell-based therapies.
Trounson A; DeWitt ND; Feigal EG
Stem Cells Transl Med; 2012 Jan; 1(1):9-14. PubMed ID: 23197634
[TBL] [Abstract][Full Text] [Related]
8. The NIH and the regenerative medicine field.
Rao M
Regen Med; 2012 Mar; 7(2):129-31. PubMed ID: 22397601
[No Abstract] [Full Text] [Related]
9. Regenerative medicine: the emergence of an industry.
Nerem RM
J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S771-5. PubMed ID: 20843840
[TBL] [Abstract][Full Text] [Related]
10. Stem cells: Hope on the line.
Hayden EC
Nature; 2014 Jul; 511(7507):19-21. PubMed ID: 24990726
[No Abstract] [Full Text] [Related]
11. Biomedical research: Growing with the flow.
Wadman M
Nature; 2011 Jun; 474(7350):241-3. PubMed ID: 21678568
[No Abstract] [Full Text] [Related]
12. The Netherlands advancing to the forefront of regenerative medicine.
Gielen K
Stem Cells Dev; 2014 Dec; 23 Suppl 1():29-31. PubMed ID: 25457958
[TBL] [Abstract][Full Text] [Related]
13. Meeting the need for regenerative therapies: translation-focused analysis of U.S. regenerative medicine opportunities in cardiovascular and peripheral vascular medicine using detailed incidence data.
Tillman B; Hardin-Young J; Shannon W; Russell AJ; Parenteau NL
Tissue Eng Part B Rev; 2013 Apr; 19(2):99-115. PubMed ID: 23031078
[TBL] [Abstract][Full Text] [Related]
14. CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine.
Weissman IL; Watt FM
Cell Stem Cell; 2016 Jul; 19(1):19-22. PubMed ID: 27392224
[TBL] [Abstract][Full Text] [Related]
15. Steering a new course for stem cell research: NIH's intramural Center for Regenerative Medicine.
Rao MS; Collins FS
Stem Cells Transl Med; 2012 Jan; 1(1):15-7. PubMed ID: 23197635
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health Center for Regenerative Medicine: putting science into practice.
Rao M
Stem Cells Dev; 2013 Dec; 22 Suppl 1(Suppl 1):4-7. PubMed ID: 24304067
[TBL] [Abstract][Full Text] [Related]
17. Tissue engineering/regenerative medicine ventures should invest early in market research to understand the future market's needs.
Gemmiti C
Tissue Eng Part B Rev; 2013 Apr; 19(2):97-8. PubMed ID: 23327734
[No Abstract] [Full Text] [Related]
18. Wind-down of stem-cell institute leaves a void.
Loring JF
Nature; 2019 Aug; 572(7768):155. PubMed ID: 31391566
[No Abstract] [Full Text] [Related]
19. Invention and business performance in the tissue-engineering industry.
Pangarkar N; Hutmacher DW
Tissue Eng; 2003 Dec; 9(6):1313-22. PubMed ID: 14670118
[TBL] [Abstract][Full Text] [Related]
20. Technology transfer from biomedical research to clinical practice: measuring innovation performance.
Balas EA; Elkin PL
Eval Health Prof; 2013 Dec; 36(4):505-17. PubMed ID: 24142938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
